 |
| Kristie Kuhl |
Finn Partners has upped Kristie Kuhl to managing partner & global health practice leader, succeeding Gil Bashe, who remains chair of the $35M unit.
She joined Finn in 2015 as US pharma & New York health head after executive VP stints at Cohn & Wolfe and Makovsky, handling marketing, regulatory law, patient advocacy and reimbursement issues.
“Kristie joined the health practice at its earliest moments and is an amazing voice for our talent, agency values and societal need,” Bashe told O’Dwyer’s.
Noting that health is one of Finn’s largest practices, Bashe said Kuhl’s promotion is a signal that "we are looking to grow careers, impact clients and create opportunities throughout the agency.”
Kuhl, who calls Finn Health a “purpose-driven organization,” said her job as practice leader “is to ensure that people have the information and resources they need to serve the most innovative health companies so that we have a positive impact on people's health.”
As chair, Bashe will continue to focus on acquisitions, strategy, client relationships and ally partnerships.
Finn’s health group has about 175 staffers.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
